In this POV, market access gurus Mike Motto, Glen Davis, and Peter Weissberg, discuss recent Trump administration action on drug pricing, the likelihood of further action before the 2020 election, and how pharma manufacturers can provide affordable options for more Americans.
As the demand for more privacy protections continues, the ad industry moves to create new standards that protect digital advertising practices, including targeting and messaging, while also maintaining consumer privacy.
Major national pharmacy chains have announced new options for patients who would like affordable, one-stop, comprehensive healthcare outside of the traditional care setting, as well as new opportunities for PCPs. Three Intouch market access experts offer considerations and opportunities for pharma marketers to navigate this growing retail healthcare delivery trend.
To better understand the impact of the new virtual health landscape, the DHC Group recently conducted research including thought leader roundtables, physician surveys via the SERMO network, and interviews with pharma marketers, including Intouch director of innovation, Brendon Thomas.
Marketing that accurately reflects the population matters more than ever. Reaching out appropriately to untapped audiences offers brands enormous potential to make a difference. In this POV, senior RM strategist Chanel Hemphill discusses best practices for marketing to the Black community.
In early March 2020, the violator - a simple badge, or on-page announcement - began to appear on websites. COVID-19 violators are now ubiquitous. Find out why this should matter to pharma marketers.
COVID-19 has been a wake-up call for pharma to evaluate their organization’s digital maturity and ability to serve customers personalized experiences. Is your organization ready?
The pandemic couldn't stop a group of Intouchers who banded together (apart) to compete in Hedera20, a global, virtual hackathon. They created HumanKind, an app that encourages and rewards acts of kindness.